covid-19 infection patient

Large trial yields strongest evidence yet that antiviral drug can help COVID-19 patients

Reading now: 136
www.sciencemag.org

Gilead's remdesivir, designed to stymie viral replication, modestly speeds the recovery of COVID-19 patients, according to a new study   By Jon CohenScience's COVID-19 reporting is supported by the Pulitzer Center.A candidate treatment for COVID-19 has shown convincing—albeit modest—benefit for the first time, in a large, carefully controlled clinical trial in hospitalized patients.The infected people who received remdesivir, an experimental drug made by Gilead Sciences that cripples an enzyme several viruses use to copy their RNA, recovered in an average of 11 days versus 15 in patients who received a placebo. “Although a 31% improvement doesn’t seem like a knockout, 100% [success], it is a very important proof of concept,” said Anthony

Read more on sciencemag.org
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA